PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Immunotherapy has been developed, which harnesses and enhances the innate powers of the immune system to fight disease, particularly cancer. PD-1 (programmed death-1) and PD-L1 (programmed death ligand-1) are key components in the regulation of the imm…